Congenital vasopressin deficiency and acute and chronic opiate effects on hypothalamo-pituitary-adrenal axis activity in Brattleboro rats

Journal of Endocrinology

Volumn 196, Issue 1, 2008, Pages 113-121

  Domokos, Ágnes ^a   Mergl, Zsuzsa ^a   Barna, István ^a   Makara, Gábor B ^a   Zelena, Dóra ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN; MORPHINE; OPIATE; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRATTLEBORO RAT; CHRONIC STRESS; CONTROLLED STUDY; DRUG ABUSE; HORMONE DEFICIENCY; HORMONE RESPONSE; HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ADRENAL GLAND; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECT; GENETICS; HYPOPHYSIS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MUTATION; PHYSIOLOGY;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ARGININE VASOPRESSIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; MORPHINE; MUTATION; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; RATS; RATS, BRATTLEBORO; RNA, MESSENGER;

EID: 38849119928     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-07-0356     Document Type: Article

References (34)

1. Aguilera G 1994 Regulation of pituitary ACTH secretion during chronic stress. Frontiers in Neuroendocrinology 15 321-350.
2. Antelman SM, Eichler AJ, Black CA & Kocan D 1980 Interchangeability of stress and amphetamine in sensitization. Science 207 329-331.
3. Antoni FA 1993 Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Frontiers in Neuroendocrinology 14 76-122.
4. Barna I, Bálint E, Baranyi J, Bakos N, Makara GB & Haller J 2003 Gender-specific effect of maternal deprivation on anxiety and corticotropin-releasing hormone mRNA expression in rats. Brain Research Bulletin 62 85-91.
5. Bohus B & de Wied D 1998 The vasopressin deficient brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin. Progress in Brain Research 119 555-573.
6. Breese GR, Knapp DJ & Overstreet DH 2004 Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist. Neuropsychopharmacology 29 470-482.
7. Briggs FN & Munson PL 1955 Studies on the mechanism of stimulation of ACTH secretion with the aid of morphine as a blocking agent. Endocrinology 57 205-219.
8. Buckingham JC 1982 Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology 35 111-116.
9. Buckingham JC & Cooper TA 1984 Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinology 38 411-417.
10. Buckingham JC & Cooper TA 1986a Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat. Neuroendocrinology 42 421-426.
11. Buckingham JC & Cooper TA 1986b Pharmacological characterization of opioid receptors influencing the secretion of corticotrophin releasing factor in the rat. Neuroendocrinology 44 36-40.
12. Coventry TL, Jessop DS, Finn DP, Crabb MD, Kinoshita H & Harbuz MS 2001 Endomorphins and activation of the hypothalamo-pituitary-adrenal axis. Journal of Endocrinology 169 185-193.
13. Dallman MF 1993 Stress update. adaptation of the hypothalamic-pituitary-adrenal axis to chronic stress. Trends in Endocrinology and Metabolism 4 62-69.
14. el Daly ES 1996 Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the rat. Life Sciences 59 1881-1890.
15. Deroche V, Piazza PV, Casolini P, Maccari S, Le Moal M & Simon H 1992 Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion. Brain Research 598 343-348.
16. Hollt V & Haarmann I 1985 Differential alterations by chronic treatment with morphine of pro-opiomelanocortin mRNA levels in anterior as compared to intermediate pituitary lobes of rats. Neuropeptides 5 481-484.
17. Houshyar H, Cooper ZD & Woods JH 2001a Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm. Journal of Neuroendocrinology 13 862-874.
18. Houshyar H, Galigniana MD, Pratt WB & Woods JH 2001b Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. Journal of Neuroendocrinology 13 875-886.
19. Houshyar H, Gomez F, Manalo S, Bhargava A & Dallman MF 2003 Intermittent morphine administration induces dependence and is a chronic stressor in rats. Neuropsychopharmacology 28 1960-1972.
20. Ignar DM & Kuhn CM 1990 Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. Journal of Pharmacology and Experimental Therapeutics 255 1287-1295.
21. Lightman SL & Young WS, III 1988 Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat. Journal of Physiology 403 511-523.
22. Maldonado R, Stinus L, Gold LH & Koob GF 1992 Role of different brain structures in the expression of the physical morphine withdrawal syndrome. Journal of Pharmacology and Experimental Therapeutics 261 669-677.
23. McNally GP & Akil H 2002 Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. Neuroscience 112 605-617.
24. Schlosser SF, Almeida OF, Patchev VK, Yassouridis A & Elands J 1994 Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type. Endocrinology 135 2058-2063.
25. Schmale H & Richter D 1984 Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats. Nature 308 705-709.
26. Simmons A 1989 Complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes. Journal of Histotechnology 12 169-181.
27. Van Tol HH, Voorhuis TA, Snijdewint FG, Boer GJ & Burbach JP 1986 Vasopressin gene expression is attenuated in the fetal Brattleboro rat. FEBS Letters 204 101-105.
28. Tribollet E, Barberis C, Jard S, Dubois-Dauphin M & Dreifuss JJ 1988 Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography. Brain Research 442 105-118.
29. Zelena D, Kiem DT, Barna I & Makara GB 1999 Alpha 2-adrenoreceptor subtypes regulate ACTH and beta-endorphin secretions during stress in the rat. Psychoneuroendocrinology 24 333-343.
30. Zelena D, Mergl Z, Foldes A, Kovacs KJ, Toth Z & Makara GB 2003a Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint. American Journal of Physiology. Endocrinology and Metabolism 285 E1110-E1117.
31. Zelena D, Mergl Z & Makara GB 2003b Maternal genotype influences stress reactivity of vasopressin-deficient brattleboro rats. Journal of Neuroendocrinology 15 1105-1110.
32. Zelena D, Barna I, Mlynarik M, Gupta OP, Jezova D & Makara GB 2005 Stress symptoms induced by repeated morphine withdrawal in comparison to other chronic stress models in mice. Neuroendocrinology 81 205-215.
33. Zelena D, Filaretova L, Mergl Z, Barna I, Toth ZE & Makara GB 2006 Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats. American Journal of Physiology. Endocrinology and Metabolism 290 E243-E250.
34. Zhou Y, Leri F, Cummins E, Hoeschele M & Kreek MJ 2007 Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin. Neuropsychopharmacology In press.